November/December 2013 - Volume 36 - Issue 9
pp: 459-495



A Phase II Study of Bevacizumab and High-dose Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma: A Cytokine Working Group (CWG) Study

Dandamudi, Uday B.; Ghebremichael, Musie; Sosman, Jeffrey A.; More

Journal of Immunotherapy. 36(9):490-495, November/December 2013.